Business Description
Linc AB
ISIN : SE0015949433
Compare
Compare
Traded in other countries / regions
LINC.Sweden6ZB.Germany IPO Date
2021-05-28Description
Linc AB is an investor in product-oriented companies in the Nordic Life Science industry. It mainly invests in and develops small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 1 | |||||
| Interest Coverage | 297.6 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 44.2 | |||||
| 3-Year EBITDA Growth Rate | -10 | |||||
| 3-Year FCF Growth Rate | -80.1 | |||||
| 3-Year Book Growth Rate | 14.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.75 | |||||
| 9-Day RSI | 43.03 | |||||
| 14-Day RSI | 42.07 | |||||
| 6-1 Month Momentum % | 35.69 | |||||
| 12-1 Month Momentum % | 63.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 167.52 | |||||
| Quick Ratio | 167.52 | |||||
| Cash Ratio | 158.21 | |||||
| Days Payable | 6.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.9 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -8299.81 | |||||
| ROE % | 43.48 | |||||
| ROA % | 43.44 | |||||
| ROIC % | 48.38 | |||||
| ROCE % | 43.9 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 3.07 | |||||
| PE Ratio without NRI | 3.19 | |||||
| PS Ratio | 1309.52 | |||||
| PB Ratio | 1.04 | |||||
| Price-to-Tangible-Book | 1.03 | |||||
| EV-to-EBIT | 2.83 | |||||
| EV-to-EBITDA | 2.83 | |||||
| EV-to-Revenue | 1214.31 | |||||
| EV-to-FCF | -14.54 | |||||
| Price-to-Graham-Number | 0.38 | |||||
| Price-to-Net-Current-Asset-Value | 13.14 | |||||
| Price-to-Net-Cash | 13.91 | |||||
| Earnings Yield (Greenblatt) % | 35.36 | |||||
| FCF Yield % | -6.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Linc AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 3.65 | ||
| EPS (TTM) (kr) | 26.847 | ||
| Beta | 0 | ||
| Volatility % | 46 | ||
| 14-Day RSI | 42.07 | ||
| 14-Day ATR (kr) | 2.166991 | ||
| 20-Day SMA (kr) | 84.595 | ||
| 12-1 Month Momentum % | 63.33 | ||
| 52-Week Range (kr) | 52.2 - 103.4 | ||
| Shares Outstanding (Mil) | 57.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Linc AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Linc AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Linc AB Frequently Asked Questions
What is Linc AB(OSTO:LINC)'s stock price today?
The current price of OSTO:LINC is kr82.50. The 52 week high of OSTO:LINC is kr103.40 and 52 week low is kr52.20.
When is next earnings date of Linc AB(OSTO:LINC)?
The next earnings date of Linc AB(OSTO:LINC) is 2024-10-24.
Does Linc AB(OSTO:LINC) pay dividends? If so, how much?
Linc AB(OSTO:LINC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers